Sectors
KMTS
Kestra Medical Technologies, Ltd.
25.30
2 x 18.23
2 x 32.88
bid
ask
-
0.34
1.33%
02:06 PM
timesize
| Ytd | -4.60% | |
| 1y | 56.75% |
25.06
day range
25.69
15.42
52 week range
30.00
| Open | 25.38 | Prev Close | 25.64 | Low | 25.06 | High | 25.69 | Mkt Cap | 1.48B |
| Vol | 79.34K | Avg Vol | 367.77K | EPS | -2.43 | P/E | N/A | Forward P/E | -12.69 |
| Beta | 0.58 | Short Ratio | 8.35 | Inst. Own | 103.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-14 | 50-d Avg | 25.09 | 200-d Avg | 23.60 | 1yr Est | 30.00 |
| Income Statement | |||
| Total Revenue | 28.64M | ||
| Revenues (USD) | 28.64M | ||
| Cost of Revenue | 12.96M | ||
| Gross Profit | 15.68M | ||
| Operating Expenses | 55.03M | ||
| Research and Development Expense | 5.63M | ||
| Selling, General and Administrative Expense | 49.39M | ||
| Operating Income | -39.34M | ||
| Interest Expense | 1.84M | ||
| Income Tax Expense | 192.00K | ||
| Net Income | -38.83M | ||
| Net Income Common Stock | -38.83M | ||
| Net Income Common Stock (USD) | -38.83M | ||
| Consolidated Income | -38.83M | ||
| Earnings per Basic Share | -0.67 | ||
| Earnings per Basic Share (USD) | -0.67 | ||
| Earnings per Diluted Share | -0.67 | ||
| Earning Before Interest & Taxes (EBIT) | -36.80M | ||
| Earning Before Interest & Taxes (USD) | -36.80M | ||
| Weighted Average Shares | 58.21M | ||
| Weighted Average Shares Diluted | 58.21M | ||
| Balance Sheet | |||
| Cash and Equivalents | 101.81M | ||
| Cash and Equivalents (USD) | 101.81M | ||
| Investments | 162.49M | ||
| Investments Current | 96.72M | ||
| Investments Non-Current | 65.77M | ||
| Trade and Non-Trade Receivables | 14.54M | ||
| Current Assets | 222.36M | ||
| Property, Plant & Equipment Net | 62.45M | ||
| Total Assets | 358.47M | ||
| Debt Current | 31.00K | ||
| Total Debt | 46.79M | ||
| Current Liabilities | 50.37M | ||
| Debt Non-Current | 46.76M | ||
| Total Liabilities | 98.81M | ||
| Accumulated Retained Earnings (Deficit) | -651.86M | ||
| Accumulated Other Comprehensive Income | -218.00K | ||
| Shareholders Equity | 259.66M | ||
| Shareholders Equity (USD) | 259.66M | ||
| Assets Non-Current | 136.11M | ||
| Total Debt (USD) | 46.79M | ||
| Inventory | 6.71M | ||
| Liabilities Non-Current | 48.44M | ||
| Trade and Non-Trade Payables | 27.30M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.38M | ||
| Net Cash Flow from Financing | -185.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -191.61M | ||
| Capital Expenditure | -9.66M | ||
| Issuance (Purchase) of Equity Shares | 113.00K | ||
| Net Cash Flow from Investing | -172.71M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -163.04M | ||
| Net Cash Flow from Operations | -18.72M | ||
| Share Based Compensation | 10.30M | ||